UICC Opens the World Cancer Leaders’ Summit 2025

World Cancer Leaders UICC

“Delivering Innovation with Integrity” - ACT 4 Children Initiative at the 2025 WCLS

ACT 4 Children

Top Growing Medical Universities in USA and Canada: 2025 Edition by BIGR

USA and Canada

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

FDA Approves Ziftomenib (Komzifti) for Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

ziftomenib

The World’s First Trial of a Vaccine to Prevent Lung Cancer - Cancer Research UK

Cancer Research UK

Pediatric Cardio-Oncology Consortium to Host Virtual Summit on December 4, 2025

Cardio-Oncology-Consortium

2025 Selected Abstracts for the European Cancer Summit - European Cancer Organisation

European Cancer Organisation European Cancer Summit

OncoCalendar

« All Events

  • This event has passed.

42nd Annual CFS: Innovative Cancer Therapy for Tomorrow

Nov 13, 2024 • 12:00 AM - Nov 15, 2024 • 12:00 AM
42nd Annual CFS: Innovative Cancer Therapy for Tomorrow

42nd Annual CFS: Innovative Cancer Therapy for Tomorrow will be held from November 13-15, 2024 at New York, USA.

Entering its 42nd year, the Chemotherapy Foundation Symposium (CFS) remains a premier event that brings together thousands of healthcare professionals for a dynamic 3-day conference focused on delivering cutting-edge, evidence-based cancer care. Esteemed faculty from around the world will share their expertise on the latest developments in cancer therapeutics, providing attendees with a unique opportunity to explore how new and innovative approaches can be integrated into current treatment paradigms to improve care for cancer patients.

With ongoing rapid progress in the management of solid and hematologic malignancies, the past year has seen significant shifts in practice, with new diagnostic, therapeutic, and supportive care strategies being implemented. At CFS, participants will gain critical insights into optimized treatments, including chemotherapies, targeted therapies, immunotherapies, and multimodal approaches that are shaping the future of oncology care.

Details

Organizer

Venue